Related Experiment Video
Updated: Feb 4, 2026
07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
15.2K
Venous Thromboembolism in Patients with Sarcoma: A Retrospective Study
Thierry Alcindor1,2, Ali Al-Fakeeh3,4, Krista Goulding3,5
1Department of Oncology, McGill University Health Centre, Montreal, Quebec, Canada thierry.alcindor@mcgill.ca.
The Oncologist
|September 28, 2018
Summary
Venous thromboembolism (VTE) affects nearly 8% of sarcoma patients. Metastatic disease and chemotherapy are key risk factors for VTE in sarcoma, warranting guideline adoption.
Area of Science:
- Oncology
- Hematology
- Medical Statistics
Background:
- Limited research exists on venous thromboembolism (VTE) in sarcoma patients.
- This study investigates clinical features associated with VTE in sarcoma.
- Understanding these features can aid in early detection and management.
Purpose of the Study:
- To identify clinical characteristics of sarcoma patients experiencing venous thromboembolism (VTE).
- To determine the incidence of VTE in a sarcoma patient cohort.
- To explore potential risk factors for VTE in this population.
Main Methods:
- Retrospective case-control study design.
- Utilized a single-institution database.
- Employed univariate and multivariate analyses (chi-square, Student's t-test).
Main Results:
- The overall incidence of VTE in sarcoma patients was 7.9%.
- Metastatic disease and chemotherapy administration were identified as significant predictive factors for VTE.
- While not statistically significant, malignant peripheral nerve sheath tumor, osteosarcoma, and liposarcoma showed higher VTE propensity.
Conclusions:
- Venous thromboembolism (VTE) is a notable complication in sarcoma patients.
- Adherence to established guidelines for cancer-associated thrombosis is recommended.
- Further research may elucidate specific sarcoma subtypes at higher VTE risk.
Related Concept Videos
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
346
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
346
01:04Venous Return
12.4K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
12.4K
01:30Venous Thrombosis I: Introduction
468
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
468
01:03Rous Sarcoma Virus (RSV) and Cancer
6.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.4K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
159
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
159
01:29Venous Thrombosis III: Interprofessional Care
372
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
372